June 30, 2016
An Illinois federal judge held Wednesday that Racketeer Influenced and Corrupt Organizations Act claims over Abbott Laboratories' alleged off-label promotion of seizure drug Depakote fail because two health benefit plans didn't show a sufficiently direct link between the company's misrepresentations and their injuries.
August 16, 2013
Abbott Laboratories Inc. was hit with a proposed class action in Illinois federal court Friday by three health benefit plans alleging it unfairly reaped hundreds of millions of dollars from third-party payors through off-label marketing and kickbacks for prescriptions of anti-seizure medication Depakote.